002365.SZ
Qianjiang Yongan Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 15.11
−8.92%Margins
Gross margin
19.3%
EBITDA margin
15.0%
EBIT margin
3.4%
Net margin
4.1%
FCF margin
3.4%
1.7%
Return on equity
1.6%
Return on assets
1.4%
Return on invested capital
0.39x
Asset turnover
CNY 112.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026